Outcomes of Transplantation with Related- and Unrelated-Donor Stem Cells in Children with Severe Thalassemia

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 6, 2006, Pages 683-687

  Hongeng, Suradej ^a   Pakakasama, Samart ^a   Chuansumrit, Ampaiwan ^a   Sirachainan, Nongnuch ^a   Kitpoka, Pimpan ^a   Udomsubpayakul, Umaporn ^a   Ungkanont, Artit ^a   Jootar, Saengsuree ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Children; Related donors; Severe thalassemia; Stem cell transplantation; Unrelated donors

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; FLUDARABINE; INFLIXIMAB; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INFANT; MALE; THAILAND; THALASSEMIA; TREATMENT OUTCOME; BETA THALASSEMIA; FAMILY; GRAFT VERSUS HOST REACTION; LIVING DONOR; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS; STEM CELL TRANSPLANTATION;

ADOLESCENT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; LIVING DONORS; MALE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33746874867     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.02.008     Document Type: Article

References (14)

1. Anasetti C., Etzioni R., Petersdorf E.W., Martin P.J., and Hansen J.A. Marrow transplantation from unrelated volunteer donors. Annu Rev Med 46 (1995) 169-179
2. La Nasa G., Giardini C., Argiolu F., et al. Unrelated donor bone marrow transplantation for thalassemia. the effect of extended haplotypes. Blood 99 (2002) 4350-4356
3. Hongeng S., Pakakasama S., Chaisiripoomkere W., et al. Outcome of transplantation with unrelated donor bone marrow in children with severe thalassemia. Bone Marrow Transplant 33 (2004) 377-379
4. Hongeng S., Chuansumrit A., Hathirat P., Rerkamnuaychoke B., Chaisiripoomkere W., and Jootar S. Full chimerism in nonmyeloablative stem cell transplantation in a β-thalassemia major patient (class 3 Lucarelli). Bone Marrow Transplant 30 (2002) 299-314
5. Hongeng S., Pakakasama S., Chaisiripoomkere W., Ungkanont A., and Jootar S. Nonmyeloablative stem cell transplantation with haploidentical donor in a class 3 Lucarelli severe thalassemia patient. Bone Marrow Transplant 34 (2004) 271-272
6. Lucarelli G., Giardini C., and Angelucci E. Bone marrow transplantation in thalassemia. In: Winter J.N. (Ed). Blood Stem Cell Transplantation (1997), Kluwer Academic, Boston 305-315
7. Smith B.R., Parkman R., Lipton J., Nathan D.G., and Rappeport J.M. Efficacy of a short course (four doses) of methotrexate following bone marrow transplantation for prevention of graft-versus-host disease. Transplantation 39 (1985) 326-329
8. Willenbacher W., Basara N., Blau I.W., Fauser A.A., and Kiehl M.G. Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab. Br J Haematol 112 (2001) 820-823
9. G K., P S., U R., et al. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody. Bone Marrow Transplant 28 (2001) 47-49
10. Le Blanc K., Rasmusson I., Sunberg B., et al. Treatment of severe graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
11. Boeckh M., Nichols W.G., Papanicolaou G., Rubin R., Wingard J.R., and Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients. current status, known challenges, and future strategies. Biol Blood MarrowTransplant 9 (2003) 543-558
12. van Esser J.W., Niesters H.G., van der Holt B., et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 99 (2002) 4364-4369
13. Gaziev D., Galimberti M., Lucarelli G., et al. Bone marrow transplantation from alternative donors for thalassemia. HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant 25 (2000) 815-821
14. Hongeng S., Krance R.A., Bowman L.C., et al. Outcome of transplantation with matched-sibling and unrelated donor bone marrow in children with leukemia. Lancet 350 (1997) 767-771